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Abstract
In liver failure, congenital enzymopathies of the urea cycle, and other disorders, 
ammonia may not be properly detoxified and thus hyperammonemia ensues. Hyperam-
monemia is considered one of the main factors leading to cerebral edema and related 
consequences (increased intracranial pressure, brain herniation, and death). Cere-
bral edema is a critical component of neurological status impairment in patients with 
hyperammonemia and hepatic encephalopathy (HE). Although cerebral edema is gen-
erally classified as cytotoxic (cellular) and vasogenic (extracellular),  both components 
often coexist in the same patient. Both types of edema can occur in acute hyperam-
monemia and liver failure with cytotoxic edema being a consequence of astrocytes 
swelling and vasogenic edema, mainly due to blood-brain barrier (BBB) disruption. 
It is well known that hyperammonemia is a crucial factor in astrocytes swelling and 
increased BBB permeability; however, the molecular mechanisms by which ammonia 
causes these alterations are not completely understood. Aquaporins (water channels) 
are one of the main pathways leading to water influx into the brain and efflux from 
the brain; consequently, it is conceivable brain aquaporins disturbances are involved in the 
pathophysiology of cerebral edema in hyperammonemia and HE. This review summa-
rizes brain aquaporins main functions and distribution, and particularly, the aquaporin 
4 (AQP-4) alterations induced under hyperammonemia and acute liver failure (ALF). 
Acuaporina cerebral 4 e hiperamonemia 
Resumen
En situaciones de insuficiencia hepática, defectos congénitos de las enzimas del ciclo 
de la urea y otras alteraciones, el amonio no puede eliminarse correctamente y apa-
rece un cuadro de hiperamonemia. La hiperamonemia se considera uno de los factores 
principales que conduce a edema cerebral y sus consecuencias (aumento de la presión 
intracraneal, herniación cerebral y muerte). El edema cerebral es una complicación im-
portante que contribuye al deterioro neurológico de los pacientes con hiperamonemia 
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Introduction
Acute hyperammonemia- and hepatic encephalopathy 
(HE)-associated brain edema  occurs following acute 
liver failure (ALF) resulting from drug hepatotoxicity, vi-
ral hepatitis, and other acute liver conditions, and has 
a very high mortality.1,2 It has been proposed that brain 
herniation resulting from cerebral edema and increased 
intracranial pressure are important steps in the patho-
genic mechanisms in ALF and ammonia intoxication.3-6 
Based on edema pathophysiology, Klatzo7 first differen-
tiated brain edema in two subtypes, namely cytotoxic 
edema and vasogenic edema. In cytotoxic edema (also 
called cellular edema), water accumulation occurs in-
side the cells, primarily astrocytes, whereas in vasogenic 
edema water accumulates in the extracellular space of 
brain parenchyma. Cytotoxic edema results primarily 
from the impairment of osmotic gradients across cell 
membranes. Such impairment results from several causes 
including lack of oxygen and cellular metabolism disrup-
tion, which on turn decreases ion-pump function resulting 
in intracellular osmoles accumulation.8,9 As water moves 
between fluid compartments following hydrostatic and 
osmotic gradients, intracellular ions accumulation leads 
to free water influx into the cells and cell volume expan-
sion. Cytoxotic edema is seen with various intoxications 
(dinitrophenol, triethyltin, hexachlorophene, isoniazid), 
Reye’s syndrome, severe hypothermia, early ischemia, 
encephalopathy, early stroke or hypoxia, cardiac arrest, 
pseudotumor cerebri, and cerebral toxins.
Vasogenic (extracellular) edema is primarily caused 
by BBB disruption leading to a subsequent leakage of in-
travascular fluid (containing water and other plasma 
constituents) into the extracellular space of the brain 
parenchyma.8  Water movement across brain capillaries 
endothelium is determined by the balance of hydrostatic 
and osmotic forces across the capillary wall. Under normal 
conditions, BBB restricts osmoles movement across the 
vascular endothelium and water flux into brain parenchyma 
is mainly driven by hydrostatic forces and ion co-trasporta-
tion. This movement is counteracted by osmotic gradients, 
which leads to minimal net fluid absorption by brain pa-
renchyma. When BBB permeability is increased, vascular 
fluid goes into the brain extracellular space. In such case, 
fluid flows into the parenchyma along hydrostatic gradi-
ents with no opposing osmotic forces leading to net fluid 
accumulation in the brain extracellular space. This type of 
edema is seen in case of tumors, neuroinflammation, later 
stages of cerebral ischemia and hypertensive encephalopa-
thy, and following brain trauma. 
In many pathologies in which cerebral edema occurs, 
either both types of edema coexist7 or one form tends to 
predominate over the other, which depends on the un-
derlying lesion and the stage of disease progression. For 
instance, cytotoxic edema appears in the early phase of 
brain ischemia while subsequently also vasogenic edema 
takes place. In acute HE and hyperammonemia both types 
of edema have been shown and often coexist.10-14 Exposi-
tion to pathophysiological levels of ammonia (5 mM), a 
level found in the brain in some experimental models of 
HE,3 ammonia causes a significant increase in cell volume 
in primary astrocyte cultures15,16 as well as in glioma cell 
lines.17 Similarly, swelling of astrocytes has been observed 
in brain slices treated with ammonia.18 Also endothelial cells 
culture respond to high ammonia levels with alterations 
of proteins of the tight junctions such as downregulation of 
claudin-12 and other molecular alterations.19-21 
Aquaporins Distribution in the Central Ner-
vous System
Water homeostasis in the brain is of crucial importance 
for both physiological and pathological mechanisms. Ce-
rebral edema is a serious finding in many central nervous 
system (CNS) pathologies such as brain trauma, infarc-
tion, inflammation, infection, and tumors as well as in 
HE, a neurological complication that may ensue following 
liver failure. Recent data suggest that the proteins ca-
lled aquaporins act (not exclusively though; see later) 
as water channels that regulate water movement in the 
brain.22-26 Over 10 of these proteins have been identified 
and seven of them are expressed in the rodent brain. 
AQP-1, 4 and 9 are the aquaporins mainly expressed in 
the brain and will be discussed separately in this review. 
Aquaporins 3, 5, 8, and 11 have also been identified in 
the rat brain although at very low densities and their role 
remains to be investigated.27
y encefalopatía hepática (EH). Aunque por lo general el edema cerebral se clasifica en 
citotóxico y vasógeno, muchas veces estos dos tipos coexisten en el mismo trastorno. 
En hiperamonemia y EH ocurren ambos: el edema citóxico se atribuye al hinchamiento 
de los astrocitos y el vasógeno se debe a la rotura de la barrera hematoencefálica. Se 
sabe que la hiperamonemia es un factor crucial en la inducción del hinchamiento de 
los astrocitos y el aumento de la permeabilidad de la barrera hematoencefálica, pero los 
mecanismos moleculares por los causa estos efectos aún no se esclarecen. Los cana-
les de agua llamados acuaporinas constituyen una de las principales vías de entrada 
y salida del agua en el cerebro; por tanto, es lógico pensar que alteraciones de estas 
proteínas participan en la patogénesis del edema cerebral en hiperamonemia y EH. 
En esta revisión se pretende resumir tanto las funciones como la distribución de las 
acuaporinas en el cerebro y, en particular, analizar las alteraciones de la acuaporina 4 
en hiperamonemia y encefalopatía hepática.
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Aquaporins 1, 4 and 9 and Regulation of 
Brain Water Homeostasis
Aquaporin 1
AQP-1 is mainly expressed in the choroid plexus of the 
lateral ventricles and probably positively modulates cer-
ebrospinal fluid (CSF) secretion;28-30 in fact, AQP-1 KO 
mice display decreased CSF production and thus reduced 
intracranial pressure.30 AQP-1 is also expressed in the 
ependymal lining and in the human hippocampus.29,31,32 
Expression of AQP-1 declines with aging33 and in patients 
with Alzheimer’s disease34 hence contributing to the slow 
fluid turnover rate observed in these situations.  
Aquaporin 4
AQP-4 is one of the most selective water channels amongst 
all aquaporins. Immunocytochemistry studies have shown 
that astrocytes but not CNS neurons express AQP-4.35,36 As 
opposed to most of the aquaporins that have been stu-
died,  AQP-4 is not inhibited by mercuric ions.
Immunogold technique studies revealed that AQP-4 in 
astrocytes is rich in  plasma membranes facing capillaries 
and the pia matter.35 In addition, AQP-4 is highly expres-
sed in astrocytes in the glial limiting border facing the 
cortical and ventricular surfaces, as well as in the basola-
teral membrane of the ventricular ependyma.37
In osmosensitive organs such as the magnocellular 
hypothalamic nuclei, AQP-4 channels are expressed on 
astrocytic plasma membranes facing both capillaries 
and magnocellular neurons and in other sites not fa-
cing the brain surface or capillaries.35,38 The specificity 
and intensity of AQP-4 staining in osmosensitive brain 
regions suggest that AQP-4 channels allow plasma osmo-
tic pressure variations to be transferred from blood to 
osmosensitive neurons. Furthermore, high blood vessel 
density is another common feature of these nuclei, which 
contributes to plasma osmolarity detection.38 Low AQP-4 
levels occur also at plasma membranes that unsheathe 
neuronal processes such as the glutamatergic synapses 
between parallel fibres and Purkinje cell spines in the 
cerebellum.35,38,39 Although AQP-4 is expressed at low 
densities by astrocytic plasma membranes that abut on 
brain neuropil, it should be pointed out that this latter 
localization has a larger distribution area as compared 
to astrocytic plasma membranes that abuts on capillaries 
and pial arteries. Non-endfeet membranes show different 
levels of expression depending on the brain region. Strong 
AQP-4 labelling of non-endfeet membranes is prominent 
in the more dorsal parts of the cortex and in the granule 
cell layer of the cerebellum. AQP-4 is also expressed in 
lower levels by endothelial cells of the brain.36,40,41 AQP-4 
is expressed both abluminally and adluminally in endo-
thelial cells.26,36,41 
AQP-4 is also expressed in the basolateral membra-
ne of ependymocytes.35 The brain regions of the rodent 
brain that show the highest level of AQP-4 protein include 
the cerebellum, the magnocellular hypothalamic nuclei, the 
hippocampus, the neocortex, and the medial habenular 
nucleus.23,42
Aquaporin 9
AQP-9 is permeable to water and other solutes such as 
ammonia, urea, and glycerol.43 However, the osmotic 
water coefficient varies between reports and it seems 
that water permeability through this aquaporin is less 
important than in pure water channels such as AQP-4.44 
Except for one report,45 experimental data demonstrate 
that AQP-9 is also permeable to glycerol, urea, polyols 
such as mannitol and sorbitol,46,47 purines (adenine), 
pyrimidines (uracil and the chemotherapeutic agent 
5-fluorouracil), and monocarboxylates such as lactate 
and beta-hydroxybutyrate mainly in their protonated 
forms.46 AQP-9 is expressed in astrocytic processes and 
cell bodies46,48-50 but, in contrast to AQP-4, it is not po-
larized on astrocytic endfeet.39 This aquaporin is also 
expressed in other cell types: endothelial cells of sub-
pial vessels49 and, unlike AQP-1 and AQP-4, AQP-9 is 
expressed in some neurons (see below).49 Two studies 
from different research groups50,51 demonstrated the ex-
pression of AQP-9 protein in tanycytes in the border of 
the third ventricle in the mediobasal hypothalamus and the 
subfornical organ,two osmosensitive brain regions. In-
terestingly, these glial cells do not express AQP-4. This 
difference suggests that AQP-9 is involved in the water 
movement between the CSF and the brain parenchyma in 
these hypothalamic structures. AQP-9 immunoreactivity 
was observed in astrocytes of the white matter (corpus 
callosum)48,49 and in the Bergmann glial cells of the cere-
bellum.49 In the mouse brain, AQP-9 is also expressed in 
astrocytes from the septum, the hippocampus, the dorso-
medial hypothalamic nucleus, and the arcuate nucleus.48 
Other Physiological Functions of 
Aquaporins
AQP-1
Although AQP-1 is permeable to other solutes and gases 
(NH3 and CO2),
52 few studies have addressed its relevance 
in additional processes occurring in CNS other than regula-
tion of water movement, particularly in CSF secretion.28-30 
AQP1 expression is enhanced in reactive astrocytes ac-
cumulating in brain lesions in Creutzfeldt-Jakob disease 
and multiple sclerosis, which suggests a role for AQP1-
expressing astrocytes in brain water homeostasis under 
some pathological conditions.53,54
AQP-4
The subcellular compartmentation of AQP-4 overlaps with 
that of the potassium channels Kir4.1; such channels are 
involved in the spatial buffering of K+, which increases in 
the extracellular space after the action potential occurs. 
In animals that lack perivascular AQP-4, K+ clearance is 
delayed and K+ buffering is positively related to the changes 
of the extracellular space volume.39,55 The role of AQP-4 
in buffering the extracellular K+ is confirmed by the fact 
that AQP-4 KO mice display a delayed potassium reup-
take during electrical activity and thus ability to develop 
seizures is increased.56 Alterations of AQP-4 and Kir4.1 ge-
nes have been shown to be interrelated in patients with 
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temporal lobe epilepsy.57 Another physiological role for 
AQP-4 is the modulation of cell adhesion.58 The high level 
of AQP-4 protein in the glia lamellae of the magnocellular 
nuclei of the hypothalamus should facilitate the adhesion 
between astrocyte processes.58 In this situation, AQP-4 
should not be involved in water diffusion but rather in 
cell adhesion between astrocytes and possibly to endo-
thelial and muscle cells in the perivascular compartment. 
This finding is supported by the fact that proper astro-
cytic AQP-4 localization depends on the presence of 
basal lamina proteins such as agrin, alpha-dextro glycan, 
and laminin.59,60
AQP-9
AQP-9 is a member of the so called aquaglyceroporins 
that facilitate the diffusion of water and several solutes 
such as glycerol, urea, and monocarboxylates. Regarding 
this aquaporin, the role of water homeostasis regulation 
should be revised because catecholaminergic neurons are 
not directly involved in the regulation of systemic osmo-
tic pressure but in energy balance.61,62 Supporting this 
notion, AQP-9 is expressed not only in plasma membrane 
of cells but also in the mitochondria of astrocytes and 
dopaminergic neurons.63 It has been postulated that the 
presence of AQP-4 facilitates the bidirectional diffusion 
of glycerol and monocarboxylates such as lactate which 
serve as energy substrates for neurons (AQP-9 would pro-
mote the influx of such solutes) and astrocytes (AQP-9 
would promote the efflux of glycerol and lactate).64-66 In 
addition, some catecholaminergic neurons are sensitive 
to changes in glucose concentration49 and are activated 
by lactate and glycerol.62,67
AQP-9 could also be involved in the regulation of mo-
nocarboxylate through the BBB. Future studies should 
show whether AQP-9 plays a role in energy balance as a 
glycerol-lactate channel.
Aquaporins, Hyperammonemia, and Hepa-
tic Encephalopathy
AQP-1
Although AQP-1 expressed in Xenopus oocytes is permea-
ble to ammonia52,68 and  abundantly distributed in the 
choroid plexus, it seems that its amount (either mRNA 
or protein) is not affected in the brain of patients expe-
riencing ALF and hyperammonemia. A preliminary report 
by Eefsen et al69 showed that the protein and mRNA 
content of AQP-1 is not altered in mice with ALF and 
hyperammonemia induced by injecting the hepatotoxin 
D-galactosamine and endotoxin lypopolysaccharide (LPS), 
and by infusing intravenously (i.v.) ammonia acetate so-
lution. No studies have yet evaluated the role of AQP-1 in 
the mediation of swelling neither in cultured astrocytes 
nor in endothelial cells exposed to ammonia. In addition, 
no differences were found in chronic liver failure regar-
ding urinary excretion of AQP-1 between healthy subjects 
and patients with cirrhosis with or without ascites, su-
ggesting AQP-1 may not play a significant role in the 
progressive dysregulation of peripheral extracellular fluid 
volume in cirrhosis.70 However, one unexplored possibili-
ty is that the  AQP-1 regulation (through phoshorylation 
or subcellular localization) rather than the total protein 
amount might be altered in hyperammonemia and hepa-
tic failure.
Aquaporin-4 in Astrocytes Cultured under 
Hyperammonemia
Cultured astrocytes exposed to ammonia show many of 
the pathological, metabolic, and neurochemical changes 
observed in human HE.6 However, extrapolation of such 
findings to in vivo situation should be done with caution 
because of the cellular/molecular differences between 
cultured cells and their in situ counterparts. Exposure 
of cultured astrocytes to 5 mM NH4Cl led to an increa-
sed protein expression of AQP-4,  which was correlated 
with the development of astrocyte swelling.71-73 AQP-4 
increase is observed 10 hours after ammonia treatment, 
and interestingly, 2 hours before the onset of astrocyte 
swelling. Such increase is observed for up to 48 hours.71 
The molecular mechanism by which exposure to ammo-
nia increases AQP-4 levels in cultured astrocytes is not 
known. Oxidative stress is known to upregulate both gene 
and protein expression of AQP-4 in cultured astrocytes.74 
Since it is well documented that oxidative stress plays a 
major role in ammonia neurotoxicity,75 it has been de-
monstrated that oxidative stress caused by ammonia may 
be responsible for AQP-4 upregulation.76 
AQP-4 in Animal Models of Hyperammone-
mia and Hepatic Encephalopathy
While the role of AQP-4 has been strongly implicated 
in brain edema associated with various neurological 
conditions, its involvement in brain edema in acute hype-
rammonemia and HE due to ALF is not well documented. 
Until now, only three reports have demonstrated an in-
creased AQP-4 expression in experimental models of 
ALF. In a preliminary report, Margulies et al.77 noted an 
increased brain AQP-4 protein expression in rats whose 
liver had been devascularized, and such an increase was 
correlated with the onset of brain edema. Similarly, Yang 
et al.78 reported an AQP-4 increase in a rat model of ALF, 
caused by the hepatotoxin thioacetamide. Another re-
port (although preliminary) by Eefsen et al.69 has shown 
that AQP-4 levels were increased in the cerebral cortex 
in mice with ALF and hyperammonemia through D-galac-
tosamine plus  LPS injection and i.v. ammonium acetate 
solution infusion. In contrast to the above mentioned stu-
dies regarding a situation of acute hyperammonemia, in 
a more chronic animal model of hyperammonemia due 
to a defect in a urea cycle enzyme (ornithine transcar-
bamaylase) it was demonstrated that hyperammonemia 
(18 hours) significantly reduced the expression of AQP-4 
in astrocytes isolated in situ from mice cerebral cortex.79 
The effects of hyperammonemia differ depending on 
reached ammonia concentrations  and length of hypera-
mmonemia exposure.80 For example, acute and chronic 
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hyperammonemia induce different effects on NMDA-ty-
pe glutamatergic receptors. Excessive activation of the 
NMDA receptors and of associated signal transduction pa-
thways plays a main role in acute ammonia toxicity and 
ammonia-induced death. In contrast, in chronic hypera-
mmonemia, levels of ammonia are not high enough to 
induce death and this seems to allow the induction of an 
adaptive response, which results in a reduced function of 
some signal transduction pathways associated to NMDA 
receptors. Consequently, it is clear that both acute (high 
levels) and moderate chronic hyperammonemia may 
affect the same processes differently, through different 
mechanisms, and can result in different (even opposite) 
effects on the same processes such as regulation of brain 
AQP-4.Aquaporin 9 and Ammonia 
AQP-9 has been shown to be permeable to ammonia 
at least when expressed in Xenopus oocytes.43,81 It was 
speculated that ammonia-permeable aquaporins might 
constitute a link between metabolism and volume con-
trol. In addition to water,  human AQP-9 are permeable to 
ammonia and urea. In humans, these aquaporins supple-
ment ammonia transportation of Rhesus (Rh) proteins 
and urea transporters (UTs) and least in periphery. The 
mechanism by which ammonia is transported by aqua-
porins is not fully understood. A comparison of transport 
equations, models, and experimental data shows that 
ammonia is transported in its neutral form (NH3).
43 
The ammonia-permeable aquaporins differ from other 
aquaporins by having a less restrictive aromatic/arginine 
region; an exclusively water-permeable aquaporin can be 
transformed into an ammonia-permeable aquaporin by 
single point mutations in this region. However, no stu-
dies have been conducted yet about the expression and 
function of AQP-9 in cultured astrocytes or brain from ex-
perimental animals with liver failure or hyperammonemia 
due to other pathologies.  
Conclusions and Future Directions
Water homeostasis is critical for the maintenance of nor-
mal cell volume82 as well as for optimal cellular metabolic 
activities.83 Brain aquaporins 1, 4 and 9 regulate water 
homeostasis in the brain.
Except for one preliminary report,69 no studies (either 
in vitro or ex-vivo) have been conducted about hypera-
mmonemia and HE effects on AQP-1 and AQP-9 content, 
regulation, or their contribution to the entry of ammo-
nia into the brain. In contrast to AQP-1 and AQP-9, more 
experimental data are available about the effect of hy-
perammonemia and HE on AQP-4. Cultured astrocytes 
exposed to ammonia display cell swelling and AQP-4 in-
crease.71-73 According to these in vitro studies, AQP-4 is 
also increased in the brain of rodents animal with ALF 
leading to acute hyperammonemia.69,77,78 In contrast, in 
an animal model of urea cycle disturbance and hypera-
mmonemia (resulting from an arginine-free diet), AQP-4 
content was significantly decreased in cerebral cortex as-
trocytes.79 The reason for these discrepancies in different 
models of acute hyperammonemia is not known but in 
the case of ALF, other metabolic abnormalities induced 
by liver failure might play a role; alternatively, different 
effects on AQP-4 could depend on the level of hyperam-
monemia reached in the brain in different animal models. 
AQP-4 role in the modulation of cytotoxic and vasogenic 
edema is different; in the latter, AQP-4 promotes cyto-
toxic edema and also allows water clearance.24,84 Another 
interesting point that remains to be investigated is the 
net contribution of AQP-4 in cytotoxic and/or vasogenic 
edema under hyperammonemia and HE. Pharmacological 
treatments that modulate brain aquaporins expression 
and function through channel gating, subcellular distri-
bution, phosphorylation, protein-protein interactions, 
and orthogonal array formation85,86 might represent new 
therapeutic targets to treat cerebral edema in hyperam-
monemia and HE. 
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